Centre of Excellence for Infectious Disease Research
CEIRR
Strengthening infectious disease research, surveillance and scientific capacity to address important public health challenges.
Advancing Infectious Disease Research
The Centre of Excellence for Infectious Disease Research brings together scientific expertise, research infrastructure and collaboration to improve understanding of infectious diseases and their impact on communities.
Through research, surveillance and scientific collaboration, CEIRR contributes to the generation of evidence that can support improved disease prevention, detection and response.
Responding to Infectious Disease Challenges
Infectious diseases continue to present significant challenges to health systems and communities.
CEIRR supports research that seeks to understand infectious disease patterns, transmission, diagnosis, surveillance and potential approaches to prevention and control.
Research • Surveillance • Capacity
Our work connects scientific research with field activities, laboratory capacity, data and collaboration to address infectious disease priorities.
Multidisciplinary Infectious Disease Research
CEIRR brings together complementary research approaches to better understand infectious diseases and strengthen public health responses.
Infectious Disease Epidemiology
Studying disease occurrence, distribution and risk factors to improve understanding of infectious disease patterns.
Disease Surveillance
Supporting surveillance approaches that can improve detection, monitoring and understanding of infectious disease threats.
Laboratory Research
Using laboratory capacity and scientific methods to support infectious disease investigation and evidence generation.
Community Health
Engaging with communities to better understand health needs, disease risks and factors influencing prevention and care.
Data & Analysis
Applying data management and analytical approaches to support high-quality infectious disease research.
Prevention & Response
Generating evidence that can contribute to improved disease prevention, preparedness and public health response.
Building Research Capacity
Strong infectious disease research depends on skilled researchers, appropriate infrastructure, reliable data and strong scientific partnerships.
CEIRR supports an environment where researchers and collaborators can work together to strengthen scientific knowledge and research capacity.
From Research Evidence to Public Health Action
Infectious disease research is most valuable when scientific evidence can contribute to better health decisions and stronger public health programmes.
CEIRR aims to contribute evidence that can help researchers, healthcare professionals, public health stakeholders and communities better understand and respond to infectious disease challenges.
Infrastructure Supporting Research
CEIRR research is supported by the broader Macha Research Trust research environment, including laboratory, field, surveillance, data and scientific infrastructure.
Explore InfrastructureResearch Through Partnership
Infectious disease challenges require collaboration across scientific disciplines and institutions.
Macha Research Trust works with research institutions, universities, healthcare organisations, communities, government stakeholders and other partners.
Interested in Collaboration?
Contact Macha Research Trust to discuss infectious disease research, scientific partnerships or other opportunities.
Contact MRTResearch Ethics & Participant Protection
Research involving human participants requires appropriate ethical review, responsible conduct and protection of participant rights and welfare.
Macha Research Trust supports responsible research practices throughout its infectious disease research activities.
Research Ethics & TrainingCEIRR Research Publications
Explore scientific publications and research outputs arising from infectious disease research conducted through Macha Research Trust and its collaborators.
Explore PublicationsStrengthening Infectious Disease Research
Through scientific research, collaboration and capacity building, we contribute to evidence that can improve understanding and response to infectious diseases.